GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PetMed Express Inc (NAS:PETS) » Definitions » Revenue

PetMed Express (PetMed Express) Revenue

: $277.2 Mil (TTM As of Dec. 2023)
View and export this data going back to 1997. Start your Free Trial

PetMed Express's revenue for the three months ended in Dec. 2023 was $65.3 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $277.2 Mil. PetMed Express's Revenue per Share for the three months ended in Dec. 2023 was $3.20. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $13.61.

Warning Sign:

PetMed Express Inc revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of PetMed Express was 3.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was -3.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was -0.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was 2.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, PetMed Express's highest 3-Year average Revenue per Share Growth Rate was 58.00% per year. The lowest was -3.80% per year. And the median was 5.60% per year.


PetMed Express Revenue Historical Data

The historical data trend for PetMed Express's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PetMed Express Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Revenue
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 283.42 284.13 309.22 273.42 256.86

PetMed Express Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.87 62.69 78.24 71.00 65.32

Competitive Comparison

For the Pharmaceutical Retailers subindustry, PetMed Express's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PetMed Express Revenue Distribution

For the Healthcare Providers & Services industry and Healthcare sector, PetMed Express's Revenue distribution charts can be found below:

* The bar in red indicates where PetMed Express's Revenue falls into.



PetMed Express Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $277.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PetMed Express  (NAS:PETS) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


PetMed Express Revenue Related Terms

Thank you for viewing the detailed overview of PetMed Express's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PetMed Express (PetMed Express) Business Description

Traded in Other Exchanges
Address
420 South Congress Avenue, Suite 100, Delray Beach, FL, USA, 33445
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies primarily to retail consumers.
Executives
Gian Fulgoni director
Christine Chambers officer: CFO 1501 1ST AVENUE SOUTH, STE. 600, SEATTLE WA 98134
Mathew N Hulett director, officer: CEO & President 1621 NORTH KENT STREET, SUITE 1200, ARLINGTON VA 22209
Campbell Leslie C.g. director C/O COUPA SOFTWARE INC., 1855 S. GRANT STREET, SAN MATEO CA 94402
Diana G Purcel director C/O FAMOUS DVES OF AMERICA INC, 8091 WALLACE ROAD, EDEN PRAIRIE MN 55344
Moseley Mark Bradley Jr other: Chief Technology Info Officer 420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445
Daniel Job Pingree other: Chief Marketing Officer 420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445
Sandra Yvette Campos director 4900 E DUBLIN GRANVILLE RD, COLUMBUS OH 43081
Jacqueline Paula Smith other: Vice President of People 420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445
Carolyn Carden other: VP of Product 420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445
Peter Cobb director DSW, INC., 810 DSW DRIVE, COLUMBUS OH 43219
Jodi Watson director 420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445
Frank J Formica director 1441 S.W. 29TH AVENUE, POMPANO BEACH FL 33069
Bruce S Rosenbloom officer: Chief Financial Officer 6401 CONGRESS AVENUE, SUITE 250, BOCA RATON FL 33487
Menderes Akdag director, officer: Chief Executive Officer 1441 S.W. 29TH AVENUE, POMPANO BEACH FL 33069

PetMed Express (PetMed Express) Headlines

From GuruFocus

PetMeds� Hires Pet-Industry Veteran into Pivotal Leadership Role

By GuruFocusNews GuruFocusNews 06-28-2022

PetMeds� Hires Pet-Industry Veteran into Pivotal Leadership Role

By GuruFocusNews GuruFocusNews 07-08-2022

PetMeds� to Acquire PetCareRx

By Stock market mentor Stock market mentor 01-17-2023

PetMeds� Hires Pet-Industry Veteran into Pivotal Leadership Role

By GuruFocusNews GuruFocusNews 06-08-2022

PetMed Express, Inc. Sets Third Quarter 2022 Earnings Call

By Stock market mentor Stock market mentor 01-23-2023

Top 5 2nd Quarter Trades of Ridgewood Investments LLC

By GuruFocus Research GuruFocus Editor 07-19-2022